The first time it happens, most people do not know what they are seeing. A small flickering spot appears near the center of the visual field. It grows slowly, spreading outward into an arc of shimmering, jagged light. The edges crackle and shift. The center clears into a blind spot. Within twenty or thirty minutes, it is gone. The headache arrives not long after.
For the roughly thirty percent of people with migraine who experience aura, that first episode is often frightening. It can look like a stroke, a detached retina, or a sign of something serious. In the absence of a diagnosis, the fear is understandable. What is actually happening in the brain is remarkable, well understood by researchers, and entirely distinct from the catastrophic causes it can resemble.
Aura is a series of transient neurological symptoms that occur in association with migraine. The word transient is important. Aura symptoms develop gradually over five to twenty minutes and resolve completely within sixty minutes in the vast majority of cases. They are reversible. They leave no lasting damage.
The International Headache Society defines aura as fully reversible symptoms including visual, sensory, or other central nervous system disturbances. For a diagnosis of migraine with aura, at least one aura symptom must spread gradually over five or more minutes, and symptoms must last between five and sixty minutes.
Aura most commonly precedes the headache phase of an attack, though it can occur alongside the headache or, in a subset of people, without any headache at all. The latter is called migraine aura without headache, or silent migraine, and it is frequently misdiagnosed because the defining feature most people associate with migraine is absent.
Visual aura is the most common type, occurring in the majority of people who experience aura of any kind. The classic presentation is a scintillating scotoma, a shimmering, flickering arc that expands gradually across the visual field, often accompanied by a blind spot at its leading edge.
The pattern is sometimes described as resembling a crescent of lightning, a fortification pattern because its jagged edges resemble the walls of a medieval fortress, or simply a ring of light that grows and then fades. It typically begins near the center of vision and expands outward over fifteen to twenty minutes before eventually leaving the visual field entirely.
Other visual aura presentations include flashes of light, wavy or blurred vision, and tunnel vision. The specific appearance varies between individuals and can vary across attacks in the same individual.
Sensory aura is the second most common type. It typically begins as tingling or numbness in the hand that spreads slowly up the arm toward the face and mouth. The march of symptoms, moving gradually from one body part to another over several minutes, is characteristic and helps distinguish it from the sudden onset of symptoms that would suggest a stroke.
Language aura, which involves difficulty finding words, slowed speech, or trouble understanding language, is less common. It occurs in a minority of people with aura and is often distressing because it can resemble the speech difficulties associated with a transient ischemic attack. The gradual onset and complete resolution within sixty minutes are the key distinguishing features.
Aura is caused by a phenomenon called cortical spreading depression, first described by the Brazilian physiologist Aristides Leao in 1944. It is a slow wave of electrical depolarization that moves across the surface of the brain at a rate of approximately three to five millimeters per minute, followed by a period of suppressed neuronal activity.
The symptoms of aura correspond directly to the regions the wave traverses. When it moves through the visual cortex at the back of the brain, visual symptoms appear. When it reaches sensory processing areas, tingling and numbness follow. When it affects language areas, speech difficulties emerge.
The wave does not cause permanent damage to brain tissue. Neuroimaging studies have confirmed that the brain returns to normal function after the wave passes. But cortical spreading depression does trigger the trigeminal nerve activation that initiates the headache phase of the attack, which is why aura so often precedes the pain.
Migraine with aura is associated with a modestly increased risk of ischemic stroke, particularly in women who smoke and use combined oral contraceptives. This risk is small in absolute terms for most people, but it is real and it warrants discussion with a healthcare provider.
The American Migraine Foundation and the American Headache Society recommend that women with migraine with aura who smoke should be strongly encouraged to quit, and that the use of combined hormonal contraceptives should be carefully evaluated in this population. These are clinical conversations, not reasons for alarm, but they are conversations worth having.
Most aura follows a predictable pattern for a given individual. When something changes, medical evaluation is warranted. New aura symptoms that have not occurred before, aura that lasts longer than sixty minutes, motor weakness during aura, or aura that occurs without a subsequent headache for the first time in someone with a history of migraine with headache, all of these changes warrant prompt medical assessment.
A sudden severe headache with no aura that is the worst headache of one's life is a medical emergency regardless of migraine history and requires immediate evaluation to rule out hemorrhagic stroke or other serious causes.
For most people with migraine with aura, the aura itself becomes familiar over time. The initial fear fades. The pattern becomes recognizable. Many find that identifying the aura is actually useful, because it provides a clear signal that an attack is imminent and creates a window to take acute medication, adjust plans, and find a safe environment before the headache phase arrives.
That window is not long. But for people who learn to use it, it can make a meaningful difference in how an attack unfolds.
International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018.
Leao AAP. Spreading depression of activity in the cerebral cortex. Journal of Neurophysiology. 1944.
Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiological Reviews. 2017.
American Migraine Foundation. Migraine with Aura. americanmigrainefoundation.org
Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk. American Journal of Medicine. 2010.
A migraine attack is not just a headache — it's a neurological event that unfolds in four distinct phases, each with its own symptoms and its own implications for treatment.
Chronic migraine remains widely misunderstood and routinely undertreated. Here's how it's defined, how it's diagnosed, and what treatment options actually exist.
Migraine was once thought to be a vascular problem. Three decades of research have rewritten that story — here's what actually happens in the brain before, during, and after an attack.
Most people have had a tension headache. Migraine is different — profoundly so. Here's how to tell them apart, and why the distinction changes what treatment looks like.
Tracking your migraines changes everything. MigraClarity helps you log attacks, identify triggers, monitor medications, and track sleep and hydration — then generates a provider-ready report you can bring to your next appointment. Create your free account and start building a clearer picture of your migraine pattern today.
Create Your Free AccountThe information in this article is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional or licensed physician before making any decisions about your health, medications, or treatment. MigraClarity is not a medical provider and nothing on this site should be used as a substitute for professional medical care.